The ABCB1 C3435T polymorphism is associated with triglyceride reduction in atorvastatin-treated Uygur patients with coronary heart disease and dyslipidemia: an observational study.
Tingting WangHao ShenTingting LiuTing ZhaoLi XuJie FengHuilan ZhangLi SunHongjian LiLuhai YuPublished in: Endocrine, metabolic & immune disorders drug targets (2023)
In patients with the ABCB1 C3435T TT genotype, atorvastatin more effectively lowered TG than other polymorphisms. This investigation may provide insights into effective individualized therapies for CHD and dyslipidemia in the Uygur population.
Keyphrases